Please Wait.....
Report
Europe Clinical Trials Market Forecast to 2028 - Regional Analysis - by Study Design (Interventional, Observational, and Expanded Access), Phase (Phase I, Phase II, Phase III, and Phase IV), and Indication (Autoimmune/Inflammation, Pain Management, Oncology, CNS Condition, Diabetes, Obesity, Cardiovascular, and Others)
Market Report I 2023-10-26 I 148 Pages I The Insight Partners
The Europe clinical trials market is expected to grow from US$ 15,739.35 million in 2022 to US$ 21,643.87 million by 2028. It is estimated to grow at a CAGR of 5.5% from 2022 to 2028.
Increasing Adoption and Outsourcing of Clinical Trials Fuels Europe clinical trials market.
Clinical trials help determine if a new form of treatment or prevention, such as a new drug, diet, or medical device, is safe and effective. The trials are mainly carried out during drug development. According to European Medicine Agency, in the European Union (EU), ~4,000 clinical trials are authorized annually, of which about 60% of clinical trials are associated with the pharmaceutical industry. An increasing number of clinical trials for developing different effective treatments due to the rising prevalence of chronic diseases is fueling the growth of the clinical trials market.
Further, clinical trials are increasingly becoming complex procedures, owing to which proper execution and overseeing of the operation occurring in research-based organizations has become crucial. To avoid errors due to improper execution, research-based organizations are outsourcing clinical trials to develop their products. Clinical research organizations (CROs) assist in successfully implementing clinical trials through the services offered using high-quality facilities and deep subject matter expertise. CROs have begun acting as a backbone of the clinical trial industry through their efficient and cost-effective operations benefitting trial sponsors. Thus, the development of cost-effective solutions and decreasing errors in CROs during the drug development process are driving the clinical trials market growth.
Europe Clinical Trials Market Overview
The Europe clinical trials market has been segmented into the UK, Germany, France, Italy, Spain, and the Rest of Europe. The rising number of clinical trial activities for new drug development and innovative product launches by the companies will likely enhance the market growth in Europe during the forecast period.
Cancer, cardiovascular illness, nervous system disorders, and infectious diseases are the most frequently studied conditions in clinical trials in Germany. Clinical research benefits from Germany's well-established transport, communication, energy, and public services infrastructure, Moreover, there is a large patient pool and a high demand for quality healthcare in the country. Coordinating centers for clinical trials were established as part of a new funding program under the Federal Ministry of Education and Research to foster academic clinical research. Clinical trials in Germany are approved by the Federal Institute for Drugs and Medical Devices or the Paul-Ehrlich Institute, depending on the product to be investigated. Therefore, Germany's clinical trial approval processes are standardized, reliable, transparent, and approved for relatively short study start-up timelines. Further, top CROs in Germany provide several clinical trial services. Sofpromed manages clinical trials in Germany and other EU member states. It offers a full range of CRO services for pharmaceutical and biotechnology companies. Similarly, CONET GmbH, headquartered in Mannheim, Germany, offers clinical trial management services from small pilot studies to large multicenter international clinical trials for all phases (1-4), including pediatric clinical trials and medical device trials as per EU Directives.
Europe clinical trials market Revenue and Forecast to 2028 (US$ Million)
Europe Clinical Trials Market Segmentation
The Europe clinical trials market is segmented into phase, study design, indication, and country.
Based on phase, the Europe clinical trials market is segmented into phase I, phase II, phase III, and phase IV. The phase III segment registered the largest Europe clinical trials market share in 2022.
Based on study design, the Europe clinical trials market is segmented into interventional, observational, and expanded access. The interventional segment held the largest Europe clinical trials market share in 2022.
Based on indication, the Europe clinical trials market is segmented into autoimmune/inflammation, pain management, oncology, CNS condition, diabetes, obesity, cardiovascular, and others. The oncology segment held the largest Europe clinical trials market share in 2022.
Based on country, the Europe clinical trials market has been categorized into the UK, Germany, France, Italy, Spain, and Rest of Europe. Germany dominated the Europe clinical trials market in 2022.
Charles River Laboratories International Inc, ICON Plc, IQVIA Holdings Inc, IXICO Plc, Laboratory Corp of America Holdings, Parexel International Corp, SGS SA, Syneos Health Inc, Thermo Fisher Scientific Inc, and WuXi AppTec Co Ltd. are some of the leading companies operating in the Europe clinical trials market.
TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Europe Clinical Trials Market - By Phase
1.3.2 Europe Clinical Trials Market - By Study Design
1.3.3 Europe Clinical Trials Market - By Indication
1.3.4 Europe Clinical Trials Market - By Country
2. Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Europe Clinical Trials Market - Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Europe PEST Analysis
4.3 Experts Opinion
5. Europe Clinical Trials Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Increasing Adoption and Outsourcing of Clinical Trials
5.1.2 Flourishing Pharmaceutical Industry and Increasing R&D Activities in Pharmaceutical Industry
5.2 Market Restraints
5.2.1 Expensive and Time-Consuming Process
5.3 Market Opportunities
5.3.1 Adoption of Decentralized Clinical Trials and Hybrid Clinical Trials
5.4 Future Trends
5.4.1 AI-Driven Clinical Trials
5.5 Impact Analysis
6. Clinical Trials Market - Europe Analysis
6.1 Europe Clinical Trials Market Revenue Forecast and Analysis
7. Europe Clinical Trials Market Revenue and Forecast To 2028 - by Study Design
7.1 Overview
7.2 Europe Clinical Trials Market Revenue Share, by Study Design (2022 and 2028)
7.3 Interventional
7.3.1 Overview
7.3.2 Interventional: Europe Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
7.4 Observational
7.4.1 Overview
7.4.2 Observational: Europe Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
7.5 Expanded Access
7.5.1 Overview
7.5.2 Expanded Access: Europe Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
8. Europe Clinical Trials Market - By Phase
8.1 Overview
8.2 Europe Clinical Trials Market, by Phase, 2022 and 2028 (%)
8.3 Phase III
8.3.1 Overview
8.3.2 Phase III: Europe Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
8.4 Phase II
8.4.1 Overview
8.4.2 Phase II: Europe Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
8.5 Phase IV
8.5.1 Overview
8.5.2 Phase IV: Europe Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
8.6 Phase I
8.6.1 Overview
8.6.2 Phase I: Europe Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
9. Europe Clinical Trials Market Revenue and Forecast To 2028 - Indication
9.1 Overview
9.2 Europe Clinical Trials Market Revenue Share, by Indication (2022 and 2028)
9.3 Autoimmune/Inflammation
9.3.1 Overview
9.3.2 Autoimmune/Inflammation: Europe Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
9.4 Pain Management
9.4.1 Overview
9.4.2 Pain Management: Europe Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
9.5 Oncology
9.5.1 Overview
9.5.2 Oncology: Europe Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
9.6 CNS Condition
9.6.1 Overview
9.6.2 CNS Condition: Europe Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
9.7 Diabetes
9.7.1 Overview
9.7.2 Diabetes: Europe Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
9.8 Obesity
9.8.1 Overview
9.8.2 Obesity: Europe Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
9.9 Cardiovascular
9.9.1 Overview
9.9.2 Cardiovascular: Europe Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
9.10 Other
9.10.1 Overview
9.10.2 Other: Europe Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
10. Europe Clinical Trials Market - Revenue and Forecast to 2028 - Country Analysis
10.1 Europe: Clinical Trials Market
10.1.1 Overview
10.1.2 Europe: Clinical Trials Market, by Country, 2022 & 2028 (%)
10.1.2.1 Germany: Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
10.1.2.1.1 Overview
10.1.2.1.2 Germany: Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
10.1.2.1.3 Germany: Clinical Trials Market, by Phase, 2020-2028 (US$ Million)
10.1.2.1.4 Germany: Clinical Trials Market, by Study Design, 2020-2028 (US$ Million)
10.1.2.1.5 Germany: Clinical Trials Market, by Indication, 2020-2028 (US$ Million)
10.1.2.2 UK: Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
10.1.2.2.1 Overview
10.1.2.2.2 UK: Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
10.1.2.2.3 UK: Clinical Trials Market, by Phase, 2020-2028 (US$ Million)
10.1.2.2.4 UK: Clinical Trials Market, by Study Design, 2020-2028 (US$ Million)
10.1.2.2.5 UK: Clinical Trials Market, by Indication, 2020-2028 (US$ Million)
10.1.2.3 France: Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
10.1.2.3.1 Overview
10.1.2.3.2 France: Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
10.1.2.3.3 France: Clinical Trials Market, by Phase, 2020-2028 (US$ Million)
10.1.2.3.4 France: Clinical Trials Market, by Study Design, 2020-2028 (US$ Million)
10.1.2.3.5 France: Clinical Trials Market, by Indication, 2020-2028 (US$ Million)
10.1.2.4 Italy: Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
10.1.2.4.1 Overview
10.1.2.4.2 Italy: Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
10.1.2.4.3 Italy: Clinical Trials Market, by Phase, 2020-2028 (US$ Million)
10.1.2.4.4 Italy: Clinical Trials Market, by Study Design, 2020-2028 (US$ Million)
10.1.2.4.5 Italy: Clinical Trials Market, by Indication, 2020-2028 (US$ Million)
10.1.2.5 Spain: Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
10.1.2.5.1 Overview
10.1.2.5.2 Spain: Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
10.1.2.5.3 Spain: Clinical Trials Market, by Phase, 2020-2028 (US$ Million)
10.1.2.5.4 Spain: Clinical Trials Market, by Study Design, 2020-2028 (US$ Million)
10.1.2.5.5 Spain: Clinical Trials Market, by Indication, 2020-2028 (US$ Million)
10.1.2.6 Rest of Europe: Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
10.1.2.6.1 Overview
10.1.2.6.2 Rest of Europe: Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
10.1.2.6.3 Rest of Europe: Clinical Trials Market, by Phase, 2020-2028 (US$ Million)
10.1.2.6.4 Rest of Europe: Clinical Trials Market, by Study Design, 2020-2028 (US$ Million)
10.1.2.6.5 Rest of Europe: Clinical Trials Market, by Indication, 2020-2028 (US$ Million)
11. Industry Landscape
11.1 Overview
11.2 Growth Strategies Done by the Companies in the Market, (%)
11.3 Organic Developments
11.3.1 Overview
11.4 Inorganic Developments
11.4.1 Overview
12. Company Profiles
12.1 IQVIA Holdings Inc
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Parexel International Corp
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 IXICO Plc
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Charles River Laboratories International Inc
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 ICON Plc
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 WuXi AppTec Co Ltd
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 SGS SA
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Syneos Health Inc
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Thermo Fisher Scientific Inc
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Laboratory Corp of America Holdings
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms
LIST OF TABLES
Table 1. Germany: Clinical Trials Market, by Phase - Revenue and Forecast to 2028 (US$ Million)
Table 2. Germany: Clinical Trials Market, by Study Design - Revenue and Forecast to 2028 (US$ Million)
Table 3. Germany: Clinical Trials Market, by Indication - Revenue and Forecast to 2028 (US$ Million)
Table 4. UK Clinical Trials Market, by Phase - Revenue and Forecast to 2028 (US$ Million)
Table 5. UK Clinical Trials Market, by Study Design - Revenue and Forecast to 2028 (US$ Million)
Table 6. UK Clinical Trials Market, by Indication - Revenue and Forecast to 2028 (US$ Million)
Table 7. France: Clinical Trials Market, by Phase - Revenue and Forecast to 2028 (US$ Million)
Table 8. France: Clinical Trials Market, by Study Design - Revenue and Forecast to 2028 (US$ Million)
Table 9. France: Clinical Trials Market, by Indication - Revenue and Forecast to 2028 (US$ Million)
Table 10. Italy: Clinical Trials Market, by Phase - Revenue and Forecast to 2028 (US$ Million)
Table 11. Italy: Clinical Trials Market, by Study Design - Revenue and Forecast to 2028 (US$ Million)
Table 12. Italy: Clinical Trials Market, by Indication - Revenue and Forecast to 2028 (US$ Million)
Table 13. Spain: Clinical Trials Market, by Phase - Revenue and Forecast to 2028 (US$ Million)
Table 14. Spain: Clinical Trials Market, by Study Design - Revenue and Forecast to 2028 (US$ Million)
Table 15. Spain: Clinical Trials Market, by Indication - Revenue and Forecast to 2028 (US$ Million)
Table 16. Rest of Europe: Clinical Trials Market, by Phase - Revenue and Forecast to 2028 (US$ Million)
Table 17. Rest of Europe: Clinical Trials Market, by Study Design - Revenue and Forecast to 2028 (US$ Million)
Table 18. Rest of Europe: Clinical Trials Market, by Indication - Revenue and Forecast to 2028 (US$ Million)
Table 19. Organic Developments Done by Companies
Table 20. Inorganic Developments Done by Companies
Table 21. Glossary of Terms
LIST OF FIGURES
Figure 1. Europe Clinical Trials Market Segmentation
Figure 2. Europe Clinical Trials Market, By Region
Figure 3. Europe Clinical Trials Market Overview
Figure 4. Phase III Segment Held Largest Share of Phase Segment in Europe Clinical Trials Market
Figure 5. The UK is Expected to Show Remarkable Growth During the Forecast Period
Figure 6. Europe: PEST Analysis
Figure 7. Europe Experts Opinion
Figure 8. Impact Analysis
Figure 9. Europe Clinical Trials Market- Revenue Forecast and Analysis - 2020- 2028
Figure 10. Europe Clinical Trials Market Revenue Share, by Study Design (2022 and 2028)
Figure 11. Interventional: Europe Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
Figure 12. Observational: Europe Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
Figure 13. Expanded Access: Europe Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
Figure 14. Europe Clinical Trials Market, by Phase 2022 and 2028 (%)
Figure 15. Phase III: Europe Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
Figure 16. Phase II: Europe Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
Figure 17. Phase IV: Europe Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
Figure 18. Phase I: Europe Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
Figure 19. Europe Clinical Trials Market Revenue Share, by Indication (2022 and 2028)
Figure 20. Autoimmune/Inflammation: Europe Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
Figure 21. Pain Management: Europe Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
Figure 22. Oncology: Europe Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
Figure 23. CNS Condition: Europe Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
Figure 24. Diabetes: Europe Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
Figure 25. Obesity: Europe Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
Figure 26. Cardiovascular: Europe Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
Figure 27. Other: Europe Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
Figure 28. Europe: Clinical Trials Market, by Key Country - Revenue (2022) (US$ Million)
Figure 29. Europe: Clinical Trials Market, by Country, 2022 & 2028 (%)
Figure 30. Germany: Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
Figure 31. UK: Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
Figure 32. France: Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
Figure 33. Italy: Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
Figure 34. Spain: Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
Figure 35. Rest of Europe: Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
Figure 36. Growth Strategies Done by the Companies in the Market, (%)
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security